C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
12/2009
12/10/2009	WO2009149436A1 Substituted aminothiazole prodrugs of compounds with anti-hcv activity
12/10/2009	WO2009148004A1 Novel compound and pharmaceutical application of same
12/10/2009	WO2009147433A1 Heterocyclic urea derivatives for the treatment of bacterial infections
12/10/2009	WO2009101082A9 Substituted sulfonic acid amide compounds
12/10/2009	WO2009015369A3 Isophthalamide derivatives inhibiting beta-secretase activity
12/10/2009	WO2008146172A3 Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans
12/10/2009	US20090306396 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same
12/10/2009	US20090306112 Antiviral protease inhibitors
12/10/2009	US20090306110 N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor
12/10/2009	US20090306074 Thiazolidinedione derivatives as p13 kinase inhibitors
12/10/2009	US20090306070 Tetra-o-substituted butane-bridge modified ndga derivatives, their synthesis and pharmaceutical use
12/10/2009	US20090306069 Azolidinone-vinyl fused-benzene derivatives
12/10/2009	US20090306059 Cyclic amine derivative having substituted alkyl group
12/10/2009	US20090306041 Inhibitors of Bruton's tyrosine kinase
12/10/2009	US20090305285 Asymmetric cyanine compounds, their preparation methods and their uses
12/10/2009	US20090304692 Triazine compounds as pi3 kinase and mtor inhibitors
12/10/2009	US20090304605 Substituted Aminothiazole Prodrugs of Compounds with Anti-HCV Activity
12/10/2009	US20090304583 Pathological tissue detection and treatment employing targeted benzoindole optical agents
12/10/2009	CA2725568A1 Heterocyclic urea derivatives for the treatment of bacterial infections
12/09/2009	EP2130820A1 Antipruritics
12/09/2009	EP2130537A1 N3 alkylated benzimidazole derivatives as mek inhibitors
12/09/2009	EP2130536A1 N3 alkylated benzimidazole derivatives as mek inhibitors
12/09/2009	EP2130534A1 Use of ritonavir for improving the pharmacokinetics of drugs metabolized by cytochrome P450
12/09/2009	EP2129666A2 Development of molecular imaging probes for carbonic anhydrase-ix using click chemistry
12/09/2009	EP2129224A1 5,6-dihydro-1h-pyridin-2-one compounds
12/09/2009	EP1745040B1 Azabicyclo(3.1.0) hexane derivatives useful as modulators of dopamine d3 receptors
12/09/2009	EP1720867B1 Process for the preparation of ziprasidone
12/09/2009	EP1409450B1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
12/09/2009	EP1300401B1 Thiazole derivatives for use as antiinflammatories
12/09/2009	EP1067109B1 Carboxylic acid derivatives and drugs containing the same as the active ingredient
12/09/2009	CN101600713A Processes and intermediates for preparing a macrocyclic protease inhibitor of HCV
12/09/2009	CN101600706A Akt活性抑制剂 Akt activity inhibitor
12/09/2009	CN101600701A Aryl sulfamide derivatives and methods of their use
12/09/2009	CN101600696A Substituted arylpyrazoles
12/09/2009	CN101597284A Anti-tumor compound preparation method
12/09/2009	CN101597259A Organic material and application thereof in organic electroluminescence device (OELD)
12/09/2009	CN101596191A Method for treatment of disease using malonyl-coa decarboxylase inhibitor
12/09/2009	CN100567293C N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists
12/09/2009	CN100567275C 5-(benz-(z)-ylidene)-thiazolidin-4-one derivatives as immunosuppressant agents
12/08/2009	US7629477 mitotic kinesins like KSP inhibitors; for treating cellular proliferative diseases; N-(3-Aminopropyl)-N [(R)-1-3-benzyl-7-chloro-4-oxo-4H-chromen-2-yl)-2-methyl-propyl]-4-methyl-benzamide
12/08/2009	US7629468 Neuroprotectants, analgesics or anticonvulsants
12/08/2009	US7629369 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation
12/08/2009	US7629362 2-pyridine carboxamide derivatives
12/08/2009	US7629348 Insecticides; for human or veterinary medicine
12/08/2009	US7629338 for treating migraine, headaches; N-[(4S)-3-Methyl-2,5-dioxo-1',3'-dihydrospiro[imidazolidine-4,2'-inden]-5'-yl]-2-((6+-)-2-oxo-6-phenylpiperidin-1-yl)acetamide
12/08/2009	US7629337 Chemokine receptor binding heterocyclic compounds
12/08/2009	CA2422807C N-substituted benzothiophenesulfonamide derivatives
12/08/2009	CA2422354C Pyrazole compounds useful as protein kinase inhibitors
12/08/2009	CA2422342C Novel amide derivatives and medicinal use thereof
12/08/2009	CA2398794C 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists
12/08/2009	CA2374898C Pyrazinyl-piperazine compounds, their use and preparation
12/08/2009	CA2315113C Pyridones as src family sh2 domain inhibitors
12/03/2009	WO2009146310A1 Deuterated tizanidine
12/03/2009	WO2009145856A1 2, 6-diamino-pyrimidin- 5-yl-carboxamides as syk or jak kinases inhibitors
12/03/2009	WO2009145360A1 Benzene or thiophene derivative and use thereof as vap-1 inhibitor
12/03/2009	WO2009145289A1 Inhibitor of analgesic tolerance
12/03/2009	WO2009145097A1 Azo metal chelate dye and optical recording medium
12/03/2009	WO2009144734A1 Process for preparation of tadalafil
12/03/2009	WO2009144494A1 Phenoxypyridinylamide derivatives and their use in the treatment of pde4 mediated disease states
12/03/2009	WO2009143992A1 2-alkoxy-substituted dicyanopyridines and use thereof
12/03/2009	WO2009115572A3 Novel heterocyclic compounds and uses therof
12/03/2009	WO2009057079A3 Novel pyrimidine derivatives
12/03/2009	WO2009053854A3 Polymorphs of dasatinib and process for preparation thereof
12/03/2009	WO2008142706A3 Novel process for the synthesis of pioglitazone and its salts thereof
12/03/2009	US20090299066 Triazolone derivatives as mmp inhibitors for the treatment of asthma and copd
12/03/2009	US20090299063 Inhibitors for Extracellular Signal-Regulated Kinase Docking Domains and Uses Therefor
12/03/2009	US20090299058 3-(5-tert-Butyl-2-Hydroxy-phenyl)-3-phenyl-1,3-dihydro-indol-2-one and/or its derivatives, used for the treatment of cellular proliferative disorders, non-proliferative, degenerative disorders, viral infections, and/or disorders associated with viral infections
12/03/2009	US20090298899 EP receptor (for which the endogenous ligand is prostaglandin E2, PGE2); {3-[(4-Chloro-biphenyl-3-carbonyl)-amino]-phenyl}-acetic acid; glaucoma or ocular hypertension; dysmenorrhoea, preterm labour, immune disorders, inflammatory disorders
12/03/2009	US20090298897 Treatment of Inflammatory Disorders With Triazole Compounds
12/03/2009	US20090298885 Methylene urea derivatives
12/03/2009	US20090298866 Indole Compounds
12/03/2009	US20090298854 Indole acetic acid derivatives and their use as pharmaceutical agents
12/03/2009	US20090298836 Thiadiazole modulators of PKB
12/03/2009	US20090298833 Piperidinyl derivatives as modulators of chemokine receptor activity
12/03/2009	US20090298832 Trisubstituted thiazole compounds, preparations methods, pharmaceutical compositions and medicals uses thereof
12/03/2009	US20090298831 Phenyl piperazine compounds, pharmaceutical composition including the same and use thereof
12/03/2009	US20090298815 Benzene Sulfonamide Thiazole and Oxazole Compounds
12/03/2009	US20090298814 Novel salts of conjugated psychotropic drugs and processes of preparing same
12/03/2009	US20090298806 Factor xa inhibitors
12/03/2009	US20090297476 Novel peptide inhibitors of hepatitis c virus replication
12/03/2009	CA2726198A1 Inhibitor of analgesic tolerance
12/03/2009	CA2725110A1 Benzene or thiophene derivative and use thereof as vap-1 inhibitor
12/03/2009	CA2723205A1 2, 6-diamino-pyrimidin- 5-yl-carboxamides as syk or jak kinases inhibitors
12/03/2009	CA2721065A1 Phenoxypyridinylamide derivatives and their use in the treatment of pde4 mediated disease states
12/02/2009	EP2128157A1 Heterocyclidene-n-(aryl)acetamide derivative
12/02/2009	EP2128156A1 Novel oxadiazole derivatives and thiadiazole derivatives having neovascularization inhibiting activity
12/02/2009	EP2125797A1 Amino- pyridine derivatives as s1p1 /edg1 receptor agonists
12/02/2009	EP2124565A2 N-substituted glycine derivatives: hydroxylase inhibitors
12/02/2009	EP1863785B1 Novel thiophene sulfoximines for treating complement-mediated diseases and conditions
12/02/2009	EP1751146B1 Pyridinyl- or pyrimidinyl thiazoles with protein kinase inhibiting activity
12/02/2009	EP1664029B1 Quinazoline derivatives as antitumor agents
12/02/2009	EP1606289B1 Carboxamide derivatives
12/02/2009	EP1551827B1 Piperidine derivatives as ccr5 inhibitors
12/02/2009	EP1349841B1 Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto
12/02/2009	CN101595105A 2-substituted 5-membered heterocycles as SCD inhibitors
12/02/2009	CN101595101A Quinolone carboxylic acids, derivatives thereof, and methods of making and using same
12/02/2009	CN101595093A Organic compounds
12/02/2009	CN101591531A Efficient red light electroluminescence material processed by solution using naphthothiadiazole as luminous center
12/02/2009	CN101591530A Fluorescent probe for detecting glutathione reductase and bioactive sulfhydryl compound as well as synthesis method and application thereof
12/02/2009	CN101591332A Compound based on 4-phenyl-6-(2, 2, 2-trifluoro-1-phenylethoxy) pyridine and application method thereof

1 ... 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 ... 628